2026-08939NoticeWallet

FDA Confirms Dexamethasone Safe for Ongoing Generic Approvals

Published Date: 5/6/2026

Notice

Summary

The FDA has decided that Dexamethasone Elixir, 0.5 mg/5 mL, wasn’t taken off the market because of safety or effectiveness problems. This means generic drug makers can keep getting approval to sell their versions, keeping options open for patients and pharmacies. No changes in costs or availability are expected, so everyone can breathe easy!

Free Policy Watch

New rules are filed every week. Most people never see them.

Pick a topic. PRIA watches every federal rule and tells you when one hits your household.

Pick a topic to get started

Analyzed Economic Effects

3 provisions identified: 2 benefits, 1 costs, 0 mixed.

FDA Finds Dexamethasone Not Withdrawn

On May 6, 2026, FDA determined that DEXAMETHASONE (dexamethasone) elixir, 0.5 mg/5 mL, was not withdrawn from sale for reasons of safety or effectiveness. FDA reviewed the files and relevant postmarketing data and found no information indicating the product was withdrawn for safety or effectiveness.

Generic Approvals Can Continue

Because FDA concluded the listed DEXAMETHASONE elixir was not withdrawn for safety or effectiveness, FDA will not begin procedures to withdraw approval of approved ANDAs that refer to this product and may continue to approve new ANDAs that refer to it so long as they meet legal and regulatory requirements. The listed product is ANDA 088254, originally approved July 27, 1983.

Possible Labeling Updates for ANDAs

FDA stated that if it determines labeling for this drug product should be revised to meet current standards, the Agency will advise ANDA applicants to submit such labeling. The product was reported discontinued by Wockhardt Bio AG in a November 16, 2021 letter and a citizen petition was submitted February 4, 2026.

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
5/6/2026

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML
Back to Federal Register

Take It Personal

Get Your Personalized Policy View

Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.

Already have an account? Sign in